Skip to Content
Biotechnology

Trump Just Said “Biotechnology” for the First Time in 353 Days as President

Biotechnology is a $350 billion-a-year industry for the U.S., but until now, President Donald J. Trump has never mentioned it. 

Why you should care: Trump hasn’t ever said the words “CRISPR,” “embryo editing,” “eugenics,” or “gene therapy,” either. Biologists are understandably anxious about what he thinks.

What he’s said now: “We are streamlining regulations that have blocked cutting-edge biotechnology, setting free our farmers to innovate, thrive, and to grow,” Trump told a meeting of the American Farm Bureau Federation in Nashville, Tennessee, on January 8. (He added, “Oh, are you happy you voted for me. You are so lucky that I gave you that privilege.”)

He’s pro-GMO? Sounds like it. KFC-loving Trump may have been referring to how, in November, his administration scrapped USDA rules that would have regulated plants created through gene-editing tools like CRISPR. 

In an e-mail, a spokesperson for the Biotechnology Innovation Organization, the industry’s trade group, confirmed it was the first time Trump has uttered the word as president.

Deep Dive

Biotechnology

The first babies conceived with a sperm-injecting robot have been born

Meet the startups trying to engineer a desktop fertility machine.

Doctors have performed brain surgery on a fetus in one of the first operations of its kind

A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.

A brain implant changed her life. Then it was removed against her will.

Her case highlights why we need to enshrine neuro rights in law.

The FDA just approved rub-on gene therapy that helps “butterfly” children

Biotech companies are getting creative with how they deliver DNA fixes into people's bodies.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.